TrialThe Lancet. Neurology2021

Safety and efficacy of intensive blood pressure lowering after successful endovascular therapy in acute ischaemic stroke (BP-TARGET): a multicentre, open-label, randomised controlled trial.

Mikael Mazighi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.